| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2017 AMENDED |
VENN STRATEGIES | EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | $390,000 | |
| 2017 AMENDED |
VENN STRATEGIES | REGENERON PHARMACEUTICALS, INC. | $60,000 | |
| 2017 AMENDED |
VENN STRATEGIES | EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | $390,000 | |
| 2017 AMENDED |
VENN STRATEGIES | EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | $390,000 | |
| 2017 AMENDED |
VENN STRATEGIES | CAMPAIGN TO END OBESITY ACTION FUND | $80,000 | |
| 2017 4th Quarter - Report |
VENN STRATEGIES | THRIVENT FINANCIAL FOR LUTHERANS | $110,000 | |
| 2017 4th Quarter - Report |
VENN STRATEGIES | CAMPAIGN TO END OBESITY ACTION FUND | $30,000 | |
| 2017 3rd Quarter - Report |
VENN STRATEGIES | THRIVENT FINANCIAL FOR LUTHERANS | $110,000 | |
| 2017 3rd Quarter - Report |
VENN STRATEGIES | CAMPAIGN TO END OBESITY ACTION FUND | $80,000 | |
| 2017 AMENDED |
VENN STRATEGIES | REGENERON PHARMACEUTICALS, INC. | $140,000 |